Her primary scientific interests are in Gene expression, Gene expression profiling, Gene, Computational biology and DNA microarray. As part of her inquiry into Genetics and Biochemistry, Cynthia A. Afshari is doing Gene expression research. Her studies in Gene expression profiling integrate themes in fields like Microarray analysis techniques, Saccharomyces cerevisiae and Pharmacology.
Her Computational biology research is multidisciplinary, incorporating elements of Design of experiments, Data mining, Mixed model and Two Color Microarray. Her research investigates the link between DNA microarray and topics such as Toxicology that cross with problems in Gene chip analysis, Carcinogen and Emerging technologies. Her CDNA Microarrays study combines topics in areas such as Toxicogenomics and Genomics.
Cynthia A. Afshari spends much of her time researching Gene expression, Gene, Gene expression profiling, Molecular biology and Genetics. In her study, which falls under the umbrella issue of Gene expression, Cancer research is strongly linked to Regulation of gene expression. Her work on Complementary DNA as part of general Gene study is frequently linked to Enzyme inducer, bridging the gap between disciplines.
The various areas that Cynthia A. Afshari examines in her Gene expression profiling study include Gene chip analysis, DNA microarray, Microarray analysis techniques and Signal transduction. Her biological study spans a wide range of topics, including Cell culture, Promoter, Telomerase reverse transcriptase and Cell biology. Cynthia A. Afshari has included themes like Toxicity, Bioinformatics and Genomics in her Toxicogenomics study.
Her scientific interests lie mostly in Pharmacology, Hepatocyte, Receptor, Cell culture and Bioinformatics. She is studying Drug development, which is a component of Pharmacology. Her Hepatocyte research incorporates themes from Liver injury, Transporter and Bile acid.
Her Receptor research integrates issues from Tocilizumab, Interleukin 6, Area under the curve and In vitro. Her Cell culture study focuses on Viability assay in particular. Her research links Toxicology with Bioinformatics.
Cynthia A. Afshari mainly investigates Transporter, Liver injury, Bile acid, Hepatocyte and Pharmacology. In the subject of general Transporter, her work in Multidrug resistance-associated protein 2, Membrane transport protein and ATP-binding cassette transporter is often linked to Progressive familial intrahepatic cholestasis, thereby combining diverse domains of study. Her Liver injury research incorporates elements of Efflux, Drug development and Bile Salt Export Pump.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Assessing Gene Significance from cDNA Microarray Expression Data via Mixed Models
Russell D. Wolfinger;Greg Gibson;Elizabeth D. Wolfinger;Lee Bennett.
Journal of Computational Biology (2001)
Microarrays and toxicology: the advent of toxicogenomics.
Emile F. Nuwaysir;Michael Bittner;Jeffrey Trent;J. Carl Barrett.
Molecular Carcinogenesis (1999)
Diverse Roles of the Nuclear Orphan Receptor CAR in Regulating Hepatic Genes in Response to Phenobarbital
Akiko Ueda;Hisham K. Hamadeh;Heather K. Webb;Yukio Yamamoto.
Molecular Pharmacology (2002)
Cloning and Characterization of the Promoter Region of Human Telomerase Reverse Transcriptase Gene
I Horikawa;P L Cable;C Afshari;J C Barrett.
Cancer Research (1999)
Gene expression analysis reveals chemical-specific profiles.
Hisham K. Hamadeh;Pierre R. Bushel;Supriya Jayadev;Karla Martin.
Toxicological Sciences (2002)
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Ryan E. Morgan;Michael Trauner;Carlo J. van Staden;Paul H. Lee.
Toxicological Sciences (2010)
Estrogen Receptor-Dependent Genomic Responses in the Uterus Mirror the Biphasic Physiological Response to Estrogen
Sylvia Curtis Hewitt;Bonnie J. Deroo;Katherine Hansen;Jennifer Collins.
Molecular Endocrinology (2003)
Prediction of compound signature using high density gene expression profiling.
Hisham K. Hamadeh;Pierre R. Bushel;Supriya Jayadev;Olimpia DiSorbo.
Toxicological Sciences (2002)
DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene.
T R Devereux;I Horikawa;C H Anna;L A Annab.
Cancer Research (1999)
Identification of putative gene based markers of renal toxicity.
Rupesh P. Amin;Alison E. Vickers;Frank Sistare;Karol L. Thompson.
Environmental Health Perspectives (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Institutes of Health
AstraZeneca (United Kingdom)
National Institutes of Health
National Institutes of Health
National Institutes of Health
Johns Hopkins University
The Jackson Laboratory
Barrow Neurological Institute
University of Mississippi Medical Center
The University of Texas MD Anderson Cancer Center
University of Strasbourg
Swansea University
Korea Institute of Science and Technology
Carnegie Mellon University
University of Tsukuba
Max Planck Society
University of Antwerp
Harvard University
University of Toronto
Karlsruhe Institute of Technology
Yale University
University of Paris-Saclay
University of Bath
Medical University of Vienna
University of New South Wales
Missouri University of Science and Technology